Title : Adjuvant epoetin-β with peginterferon-α and ribavirin in Japanese ribavirin-intolerant relapsed patients with chronic hepatitis C genotype 2.

Pub. Date : 2014 Oct

PMID : 24119110






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Erythropoietin is widely used in the USA and some other Western countries to maintain doses of ribavirin during peginterferon/ribavirin-based treatment for chronic hepatitis C virus (HCV) infection. Ribavirin erythropoietin Homo sapiens
2 Erythropoietin is widely used in the USA and some other Western countries to maintain doses of ribavirin during peginterferon/ribavirin-based treatment for chronic hepatitis C virus (HCV) infection. Ribavirin erythropoietin Homo sapiens
3 Here, we report the cases of three Japanese ribavirin-intolerant relapsed patients with HCV genotype 2 who achieved SVR from retreatment by adding erythropoietin. Ribavirin erythropoietin Homo sapiens
4 Until the next-generation antiviral treatments for HCV genotype 2 become available, the addition of erythropoietin to dual therapy can be a treatment of choice for ribavirin-intolerant relapsed patients. Ribavirin erythropoietin Homo sapiens